AIM Vaccine Co.,Ltd. Company Profile, Contacts & Intelligence

AIM Vaccine Co.,Ltd. Overview

AIM Vaccine Co Ltd is a publicaly listed company in Hong Kong principally engaged in the research and development, manufacturing and sales of vaccine. The Company's products mainly include recombinant hepatitis B vaccine, human used rabies vaccine, inactivated hepatitis A vaccine, mumps vaccine, inactivated hemorrhagic fever with renal syndrome vaccine and MPSV4. The Company's products are mainly used for the prevention of hepatitis B, hepatitis A, mumps, hemorrhagic fever with renal syndrome, rabies and meningococcal diseases. With over 70% revenue reinvested to research, The Company's candidate pipeline include messenger RNA (mRNA) corona virus disease 2019 (COVID-19) vaccine, inactivated COVID-19 vaccine, broad-spectrum COVID-19 vaccine, RSV (mRNA), PCV13, PPSV23 and MCV4. The Company principally conducts its businesses in the domestic market, with vision to increase equitable access of vaccine world wide.

Headquarters

Shanghai, Shanghai Shi, Cn

Website

en.aimbio.com

Industry

Pharmaceutical Manufacturing

Founded

2011

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

AIM Vaccine Co.,Ltd. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

AIM Vaccine Co.,Ltd. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to AIM Vaccine Co.,Ltd.

Explore companies in related markets and compare their industry and employee estimates.